Arcadia Biosciences, Inc.
RKDAArcadia Biosciences (Nasdaq: RKDA) is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Next month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is Arcadia Biosciences, Inc.'s next FDA catalyst?→
Arcadia Biosciences, Inc.'s (RKDA) next tracked catalyst is a Earnings expected November 6, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track RKDA biotech catalysts?→
Add RKDA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Arcadia Biosciences, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.